Rosylyn Pharmaceuticals Private Limited

Founded in 2019 and headquartered in Madhya Pradesh, India.

2019 | Rewa, Madhya Pradesh (India) | Active
Last Updated:

Rosylyn Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth -11.38%
  • Profit Growth -12.13%
  • Ebitda -35.26%
  • Net Worth 32.04%
  • Total Assets 76.47%

About Rosylyn Pharmaceuticals

Rosylyn Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 January 2019 (Six years and four months 19 days old ). Its registered office is in Rewa, Madhya Pradesh, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Pankaj Patel and Kalpana Patel serve as directors at the Company.

Company Details

  • Location

    Rewa, Madhya Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999MP2019PTC047508

  • Company No.

    047508

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Jan 2019

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Gwalior

Industry

Pharma
Company report

Rosylyn Pharmaceuticals Private Limited

Explore comprehensive data for Rosylyn Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Rosylyn Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Pankaj Patel Country flag representing In Director 14-Jan-2019Current
Kalpana Patel Country flag representing In Director 14-Jan-2019Current

Financial Performance of Rosylyn Pharmaceuticals.

Rosylyn Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.38% decrease. The company also saw a substantial fall in profitability, with a 12.13% decrease in profit. The company's net worth Soared by an impressive increase of 32.04%.

Rosylyn Pharmaceuticals revenue growth over time
Rosylyn Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-11.38%
Revenue from Operations
-11.38%
Total Assets
76.47%
Profit or Loss
-12.13%
Net Worth
32.04%
EBITDA
-35.26%

What is the Ownership and Shareholding Structure of Rosylyn Pharmaceuticals?

Unlock access to Rosylyn Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Rosylyn Pharmaceuticals?

Unlock and access historical data on people associated with Rosylyn Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Rosylyn Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rosylyn Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rosylyn Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rosylyn Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Rosylyn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Rosylyn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior.

  • Director Appointment

    Pankaj Kumar Patel was appointed as a Director was appointed as a Director on 14 Jan 2019 & has been associated with this company since 6 years 4 months .

  • Director Appointment

    Kalpana Patel was appointed as a Director was appointed as a Director on 14 Jan 2019 & has been associated with this company since 6 years 4 months .

  • Company Incorporation

    Rosylyn Pharmaceuticals Private Limited was registered on 14 Jan 2019 with Roc Gwalior & aged 6 years 4 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Rosylyn Pharmaceuticals Private Limited?

    Rosylyn Pharmaceuticals Private Limited was incorporated on 14 Jan 2019.

  • What is authorized share capital and paid-up capital of Rosylyn Pharmaceuticals Private Limited?

    The authorized share capital of Rosylyn Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Rosylyn Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Rosylyn Pharmaceuticals Private Limited.

    • Pankaj Kumar Patel
    • Kalpana Patel
  • What is the registered address of Rosylyn Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Rosylyn Pharmaceuticals Private Limited is Rakesh Patel Ward No. 10/807 Paras Nagar Po. Engineering College Anantpur, Teh- Huzur India, Rewa, Madhya Pradesh, 486001.

  • What is the corporate identification number (CIN) and company number of Rosylyn Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Rosylyn Pharmaceuticals Private Limited is U74999MP2019PTC047508 and the company number is 047508 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Rosylyn Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Rosylyn Pharmaceuticals Private Limited has fallen by -11.38%.

  • What change has been observed in the net worth of Rosylyn Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Rosylyn Pharmaceuticals Private Limited has experienced an upsurge of 32.04%.

  • When was the last Balance Sheet of Rosylyn Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Rosylyn Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial